CCRT Followed by Tegafur, Gimeracil and Oteracil Potassium in Cervical Cancer

Summary

This is a single institute, single-arm, interventional trial to evaluate the efficacy and toxicity of concurrent chemoradiotherapy (CCRT) followed by Tegafur, Gimeracil and Oteracil Potassium Capsules consolidation chemotherapy in patients with locally advanced cervical cancer.

Timeline

Start

2020-04-15

Primary completion

2024-04-15

Completion

2026-04-15

Drugs

Indications